Critical Care

official impact factor 4.60

This article is part of the supplement: Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma

Email this article to a friend

Preclinical trauma studies of recombinant factor VIIa

Martin A Schreiber*, John B Holcomb and Rasmus Rojkjaer

Critical Care 2005, 9(Suppl 5):S25-S28 doi:10.1186/cc3782

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.